Table 2.
Comparing symptom relief and adverse outcomes of treatments between intervention (sumatriptan and propofol) and control (sumatriptan and placebo) groups
| P | Control (n=30) | Intervention (n=29) | Variable |
|---|---|---|---|
| Pain relief# | |||
| 0.024 | 6.9 ± 1.8 | 4.6 ± 2.9 | 30 minutes |
| 0.012 | 5.5 ± 2.6 | 2.2 ± 2.7 | 1 hour |
| Other symptoms’ relief | |||
| 0.001 | 8 (26.7) | 24 (82.8) | Photophobia |
| 0.033 | 14 (46.7) | 22 (75.9) | Nausea |
| 0.232 | 5 (16.7) | 9 (31.2) | Vomiting |
| 0.353 | 1 (3.3) | 3 (10.3) | Phonophobia |
| Ondansetron requirement | |||
| 0.001 | 24 (80.1) | 7 (24.1) | Number (%) |
| Recurrence of symptom | |||
| 0.254 | 6 (20.0) | 10 (34.5) | Number (%) |
| Adverse outcomes | |||
| 0.001 | 20 (66.7) | 0 (0.0) | Chest tightness |
| 0.05 | 0 (0.0) | 7 (24.1) | Bradycardia and hypotension |
| 0.49 | 0 (0.0) | 3 (10.3) | Other adverse effects |
Data are presented as mean ± standard deviation or number (%). #: based on visual analogue scale.